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Objective:Varicose vein recurrence of the great saphenous vein (GSV) is a common, costly, and complex problem. The aim
of the study was to assess feasibility of endovenous laser ablation (EVLA) in recurrent varicose veins of the GSV and to
compare this technique with conventional surgical reintervention.
Methods: Case files of all patients treated for GSV varicosities were evaluated and recurrences selected. Demographics,
duplex scan findings, CEAP classification, perioperative data, and follow-up examinations were all registered. A
questionnaire focusing on patient satisfaction was administered.
Results: Sixty-seven limbs were treated with EVLA and 149 were surgically treated. General and regional anesthesia were
used more in the surgery group (P < .001). Most complications were minor and self-limiting. Wound infections (8% vs
0%; P< .05) and parasthesia (27% vs 13%; P< .05) were more abundant in the surgery group, whereas the EVLA-treated
patients reported more delayed tightness (17% vs 31%; P < .05). Surgically-treated patients suffered less postoperative
pain (P< .05) but reported a higher use of analgesics (P< .05). Hospital stay in the surgery group was longer (P< .05)
and they reported a longer delay before resuming work (7 vs 2 days; P < .0001). Patient satisfaction was equally high in
both groups. At 25 weeks of follow-up, re-recurrences occurred in 29% of the surgically-treated patients and in 19% of the
EVLA-treated patients (P  .511).
Conclusion: EVLA is feasible in patients with recurrent varicose veins of the GSV. Complication rates are lower and
socioeconomic outcome is better compared to surgical reintervention. (J Vasc Surg 2009;50:1106-13.)Varicose veins are a widespread affliction, causing
symptoms varying from minor leg discomfort to chronic
disabling venous ulceration. About half of the adult popu-
lation has minor stigmata of venous insufficiency, whereas
15% of men and 35% of women have visible varicose veins.1
The majority (70%) of varicose veins are the result of an
incompetent saphenofemoral junction (SFJ) and/or great
saphenous vein (GSV).2 Approximately one-third of these
patients eventually undergo surgical intervention.3
Recurrence of varicose veins after conventional surgical
treatment is a common, costly, and complex problem,
which accounts for over 20% of patients requiring venous
surgery.4-6 Recurrences may be due to residual varicose
veins, true recurrences, or progression of disease.7 Data on
recurrence rates are hard to compare because of differences
in the initial treatment, the method of measuring recur-
rence, and duration of follow-up. The rate of recurrences
seems to increase with time.8 Clinical recurrence rates of
26% to 62% have been described after a follow-up period of
3 to 11 years.9,10 Recurrences on duplex ultrasound scan-
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1106ning, however, may be even higher. Fischer et al4 described
a clinical recurrence rate of 47%, but a 60% recurrence rate
was seen in duplex scanning after a follow-up of 34 years.
Conventional treatment of recurrent varicosities of the
GSV usually consists of a surgical redisconnection of the
SFJ, frequently combined with multiple phlebectomies.
Surgical reintervention is associated with a higher re-
recurrence rate than primary treatment of varicose veins.11
Various randomized controlled trials assessing new surgical
techniques have been performedwith varying success. A com-
plete resection of theGSV stump and inversion suturing of the
common femoral vein did not seem to decrease neovasculari-
zation.12 Results on the use of barrier materials are conflicting
and these techniques have also not yet been introduced into
common clinical practice.13,14
The role of endovenous techniques in the treatment of
recurrences has not been studied to date. Results of en-
dovenous laser ablation (EVLA) for the treatment of pri-
mary GSV varicosities are at least comparable with conven-
tional surgical treatment, with early success rates of 88% to
100%.15-18 Endovenous techniques seem to offer advan-
tages over conventional treatment in terms of reduced
postoperative pain, shorter sick leaves, faster return to
normal activities, and better cosmetic results. It seems to be
cost-saving for society, especially among employed pa-
tients.19,20 The aim of the present study was to assess the
role of EVLA in the treatment of recurrent varicosities of
the GSV and to compare this technique with surgical
re-exploration.
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Study population. Case files of patients who were
treated in the Rijnstate Hospital for varicosities of the GSV
from May 2006 until October 2008 were examined. All
patients treated for recurrent varicosities of the GSV were
included. All patients were sent a letter in advance giving
information on the study and asking them to participate.
Informed consent was asked and given by all participants.
Recurrence was defined as the existence of a reconnec-
tion with the femoral vein on color-flow duplex ultrasound
scanning concurrent with GSV insufficiency. Recurrence
was defined as insufficiency (1 second reversed flow)21 in
a part of the GSV and reflux at the SFJ after prior ligation at
the SFJ and/or stripping of the GSV on duplex scanning.
All patients previously underwent a saphenofemoral dis-
connection (SFD) with or without stripping of the GSV.
Patients with an isolated insufficiency of superficial system,
without existence of a reconnection at the SFJ, were ex-
cluded. Patients who had only been treated with a phlebec-
tomy were also excluded. Various included patients were
initially operated on in other centers. Reliable data on
the duplex scan findings of their initial pathology and
details on their initial treatments could, therefore, not be
provided. The study categories were defined as recurrent
GSV varicosities treated with either EVLA or conven-
tional surgery.
Demographics and history of previous treatment for
varicose veins were noted, as was the preoperative clinical
disease severity using the CEAP classification (Table I).
Patients were classified with secondary varicosis if the deep
venous system was insufficient at preoperative duplex scan-
ning in combination with a history of deep venous throm-
bosis. The interval between initial treatment and current
treatment was recorded, as was the follow-up time between
intervention and interview. Perioperative data for compar-
ison of the two treatment modalities were obtained from
the operation report and medical file. For the surgical
intervention group, the types of procedure were recorded,
and for the EVLA group the treated length, duration of
laser application in seconds, and the fluence, defined as
J/cm2, were recorded. Moreover, the occurrence of post-
operative complications, pain, the use of analgesics and
compression stockings, and physical activities were noted.
The delay before resuming work was defined as the period
before all regular working activities could be resumed. A
prospectively taken questionnaire,22 focusing on patient
satisfaction, was sent to all patients. Two weeks afterwards,
patients were interviewed by two of the authors (L.v.G. and
L.F.). The interviewers were not involved in the treatment
of these patients. Satisfaction and subjective improvement
of symptoms were scored on a 1-10 scale. The question-
naire consisted of questions, with a visual analogue scale
outcome on a 1-10 scale. Data retrieved from the case files
were completed and confirmed and a questionnaire focus-
ing on patient satisfaction was administered.Treatment protocols
Conventional surgery. The preferred technique was a
flush division of the new SFJ, whereby the femoral vein was
exposed over a prolonged segment and all tributaries were
divided through a groin incision of 4-7 cm. If possible, the
GSV and/or anterolateral branch were stripped. Addition-
ally, a phlebectomy, according to the Mullerian technique,
was performed: using skin incisions as small as 1 mm, veins
were extracted with a phlebectomy hook or mosquito
clamp. Incisions were closed with tissue glue (Indermil
Tissue Adhesive, Covidien Syneture, Mansfield, Mass) or
intracutaneous stitches (Monocryl, Ethicon, Johnson &
Johnson, Langhorne, Pa). Thigh-high compression stock-
ings (30 to 40 mm Hg) were prescribed for 1 week after
surgery. A prolonged use was allowed for reasons of com-
fort. All patients were scheduled for out-clinic control,
without a routine duplex scan investigation.
EVLA. Suitability for EVLA was assessed on the pre-
operative duplex scan. Contraindications for EVLA in-
cluded severe tortuosity, thrombus, and a vein diameter of
less than 4 mm. The GSV was punctured, ultrasound-
guided, and a 0.035-inch J-tipped guidewire was intro-
duced into the GSV and passed to the level of the SFJ. A
5Fr catheter introducer sheath was inserted over the guide-
wire into the vein. The position of the sheath, 20mmbelow
the SFJ, was confirmed with ultrasound scan imaging. A
sterile, bare-tipped 600-m diameter laser fiber (Diomed,
Andover, Mass) was inserted into the sheath and connected
to the 810-nm diode laser (Diomed). Confirmation of the
position of the laser tip was accomplished using both du-
plex ultrasound scan and visualizing the red aiming-beam
through the skin. The tissue surrounding the saphenous
vein was then infiltrated with tumescent aesthetic. Thermal
laser energy was applied from the SFJ to the access site by
slowly withdrawing the laser fiber and sheath. During the
withdrawal, the vein was compressed manually to oppose
the vein walls and aid in the obliteration of the lumen.
Table I. The CEAP classification
Mark Definition
C Clinical signs (grade 0-6), supplemented by (s) for
symptomatic and (a) for asymptomatic presentation.
E Etiologic classification (congenital, primary, secondary).
A Anatomic distribution (superficial, deep, or perforator,
alone or in combination).
P Pathophysiologic dysfunction (reflux or obstruction,
alone or in combination).
Grade Description
C 0 No evidence of venous disease.
C 1 Superficial spider veins (reticular veins) only.
C 2 Simple varicose veins only.
C 3 Ankle edema of venous origin.
C 4 Skin pigmentation in the gaiter area (lipodermatosclerosis).
C 5 A healed venous ulcer.
C 6 An open venous ulcer.Thigh-high compression stockings (30 to 40mmHg) were
and (%
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allowed for reasons of comfort. Routine duplex scanning
was performed 6 weeks after treatment and all patients were
scheduled for out-clinic control.
Statistics. Data are presented as mean and standard
deviation or as median and range, depending on whether the
variablewas normally distributed.Differences betweengroups
were tested using the Pearson 2 test and t test. In case of
unevenly distributed variables, differences between groups
were tested using the Mann-WhitneyU test. Recurrence-free
rates were estimated using the Kaplan-Meier method, and
differences were assessed using the log-rank test. A P value of
 .05 was considered to be significant.
RESULTS
Demographic data. In the study period, a total of
1068 limbs were treated for varicose veins of the GSV, of
which 216 procedures (20%) were performed for recur-
rences. Of the 436 surgically-treated legs 34.2% (n  149)
were done for recurrences and of the 632 EVLA-treated
legs 11% (n  67; P  .0001). In the EVLA group, 6
patients (9.8%) were treated bilaterally for recurrent vari-
cosities and in the surgical group 32 patients (27.3%).
Demographic data were comparable: the surgical group
contained 17% males and the EVLA group 18% males, the
mean ages were 53.7  12.3 years and 54.1  11.2 years,
respectively. Themedian time between treatment for recur-
rence and initial treatment was 13.5 (range, 0.3-37) years
in the EVLA group and 10 (range, 0.76-39) years in the
surgery group (P  .06). The median time between treat-
ment of recurrences and last postprocedure contact was
13.5 months (range, 3-31) in the surgery group and 15.0
months (range, 3-31) in the EVLA group (P  .06).
The questionnaire was completed by 62 patients
(92.5%) in the EVLA group, and 132 patients (88.6%) in
the surgical group. Eleven patients, in whom 14 recur-
rences were treated, were not included due to failure to
contact after five or more attempts spread over 1 month.
Five patients, with six treated recurrences, were not in-
Table II. Previous treatment modalities of patients with r
Treatment history EVLA n  67,
Surgery n  149
Number of
procedures
Saphenofemoral disconnection 1
2
3
Strip GSV to knee level 1
2
Strip GSV to ankle level 1
2
Phlebectomy thigh 1
2
Phlebectomy leg 1
2
GSV, Great saphenous vein; EVLA, endovenous laser ablation.
Patients were treated with either surgery or EVLA. Data are presented as ncluded because contact information was incorrect andcould not be verified by their family physician. One patient,
with two treated limbs, refused to cooperate.
History and risk factors. All patients had at least once
been treated previously with an SFD (Table II). Of the
surgically-treated legs, 87% had previously been stripped,
19 legs (13%) were treated with SFD only, and 8 legs (5%)
were treated twice; subsequently with a strip until knee level
(short strip), and a strip until ankle level (long strip) of the
GSV. In the EVLA group, 57% were previously stripped
and 1 patient had been treated twice in the same leg:
subsequently with a long strip and a short strip of the GSV.
In the surgery group, more patients previously underwent a
thigh phlebectomy (P .05), and sclerocompression ther-
apy was significantly more abundant in the EVLA group
(P  .01).
Risk factors for development of varicosities were similar
in both groups. In the surgery and EVLA group, respec-
tively, 87% and 89% had a family history for varicose veins,
92% and 94% of female patients had one or more pregnan-
cies, and 58% and 57% had working activities in a standing
profession for more than 3 years, respectively. Thirteen
percent of patients in the surgery group and 5% in the
EVLA group had a history of deep venous thrombosis (P
.06). A history of crural ulceration, not present at time of
treatment, was present in 2% in the surgery group and in
10% in the EVLA group (P  .03). Factors that may
contribute to altered anatomy and disturbance of the ve-
nous system were similar in both groups: in the surgery
group and EVLA group, respectively, major burns ap-
peared in 2% and 3% (P  .68) leg fractures in 4% and 2%,
(P  .41), prosthesis placement 3% and 2% (P  .75),
and inguinal hernia repair was performed in 5% and 7%
(P  .75).
Preoperative duplex, CEAP classification, and
symptoms. The preoperative duplex scan observations
have been described in Table III. ThemeanmaximumGSV
diameter was 6.1 1.9 mm in the EVLA group and 6.4
1.8 mm in the surgery group (P  .66). Tortuosity was an
exclusion criterion in 55 (37%) of the 149 surgically-treated
ent varicose veins of the GSV
EVLA Surgery P value
56 84% n  124 83% .721
10 15% n  20 13%
1 1% n  5 3%
23 34% n  67 45% .142
0 0% n  3 2%
13 19% n  67 45% .001
2 3% n  1 1%
11 18% n  45 34% .09
1 2% n  1 1%
15 25% n  51 39% .194
1 2% n  1 1%
) unless otherwise specified.ecurr
n 
n 
n 
n 
n 
n 
n 
n 
n 
n 
n legs. In 12 patients (8%), the diameter was 4 mm and
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wed thrombophlebitis on duplex scan. In 76 surgically-
treated patients (51%), there were other reasons for surgical
treatment; mostly the veins were too branched or superfi-
cially positioned. Some veins had too many connections
with the DVS and/or the small saphenous vein to be
considered treatable with EVLA. No double systems
were found at preoperative duplex scanning of the
treated legs.
The preoperative CEAP classification is shown in Table
Table III. The preoperative duplex examination of
patients with recurrent varicose veins of the GSV treated
with either surgery or EVLA
Preoperative duplex
EVLA n  67, Surgery n  149 Surgery EVLA
P
value
SFJ insufficiency
Groin 131 88% 63 94% .170
Lower level 18 12% 4 6% .170
GSV insufficiency
Thigh 136 91% 66 99% .106
Leg 126 85% 63 94% .064
Anterolateral branch insufficiency 50 34% 16 24% .153
Concurrent SSV insufficiency 32 22% 16 24% .694
Concurrent SPJ insufficiency 20 13% 10 15% .768
Deep venous insufficiency
Iliac vein 0 0% 1 2% .135
Femoral vein 2 2% 1 1% .930
Popliteal vein 4 3% 0 0% .176
Gastrocnemic vein 7 5% 1 2% .249
EVLA, Endovenous laser ablation; SFJ, saphenofemoral junction; GSV,
great saphenous vein; SSV, small saphenous vein; SPJ, saphenopopliteal
junction.
Data are presented as n and (%) unless otherwise specified.
Table IV. CEAP classification of patients with recurrent
varicose veins of the GSV treated with either surgery or
EVLA
Preoperative CEAP
classification EVLA
n  67, Surgery
n  149 EVLA Surgery
P
value
Clinical status
C2 n  25 37% n  65 44% .02
C3 n  12 18% n  45 30%
C4-6 n  30 45% n  39 26%
Etiology
Ep n  64 97% n  144 98% .806
Es n  2 3% n  3 2%
Anatomy
As n  55 83% n  127 86% .526
Ap n  8 12% n  14 9%
Ad n  3 5% n  7 5%
GSV, Great saphenous vein; EVLA, endovenous laser ablation; Ep, primary
etiology; Es, secondary etiology; As, anatomy; superficial vein insufficiency;
Ap, anatomy; perforator vein insufficiency; Ad, anatomy; deep vein insuffi-
ciency.
Data are presented as n and (%) unless otherwise specified.IV. The EVLA-treated patients had a significantly worseclinical status. There was no significant difference in aetiol-
ogy, anatomy, or pathophysiology between groups. Leg
discomfort, eg, cramps, restless legs, and tiredness, were
present in 89% of the patients in the EVLA group and in
90% of patients in the surgical group (P  .84). Pain was
present in 53% and 65%, respectively, (P .13), and itching
in 42% and 36% (P .36). Cosmetics were expressed to be
of importance in 95% of the surgically-treated patients and
in 71% of the EVLA-treated patients (P  001).
Procedure
EVLA. Technical success was achieved in 100% of the
cases, including the 36 previously stripped legs. The oper-
ation was performed using local anesthesia in 95.5%, under
regional anesthesia in 3%, and under general anesthesia in
1.5%. Access to the GSV was always accomplished by
puncture. A mean length of 35  11 cm was treated with
77  13 J/cm. In 16 cases (24%), the contralateral GSV
was treated in the same session. No concomitant phlebec-
tomies or perforantectomies were performed. All patients
were discharged on the day of treatment. A postoperative
color-flow duplex scan was made in 46 legs (69%) after an
average of 8 2.5 weeks. In all patients the GSV remained
occluded and no signs of deep venous thrombosis were
found on duplex scan. Twelve patients (19.7%) were addi-
tionally treated with sclerocompression therapy for residual
reticular veins.
Conventional surgery. The procedure was perfor-
med successfully in all legs. The operation was significantly
more often performed under regional anesthesia (85%; P
.0001) and general anesthesia (15%; P .001). In 130 legs
(87%), a re-SFD was performed, and in all these procedures
the deep venous system was visualized. In 23 legs (15%) a
short strip of the GSV was performed and in 2 legs (1%) a
long strip was performed. In 14 legs (10%), an anterolateral
branch was stripped. In 7 legs (5%), perforating veins were
ligated. In 120 legs (81%), phlebectomy on the thigh was
performed, and in 99 legs (66%), on the leg. In 99 cases
(66%) the contralateral side was treated in the same session.
Twelve patients (9%) remained in the hospital overnight,
which was significantly more than in the EVLA-treated
group (P  .01). Thirty-two patients (24%) received addi-
tional sclerocompression therapy for residual reticular veins
(P  .48).
Complications and follow-up. The postoperative
pain score was significantly lower in the surgery group;
4.7 2.6 points compared to 5.7 2.5 points in the EVLA
group (P  .02). The median duration of postoperative
pain was also shorter in the surgery group (4.5 days [range,
0-42] vs 7 days [range, 0-49] P .03). In contrast, the use
of NSAIDs was significantly higher in the surgical group (0
days [range, 0-28] in the surgery group vs 0 days [range,
0-21] in the EVLA group, P  .04). Surgically-treated
patients had a significantly longer delay before resuming
work (surgery 7 days [range, 0-42] vs EVLA 2 days [range,
0-21] P  .0001). The return to a normal level of activity
was not significantly different (surgery 21 days [range,
0-170] vs EVLA 17.5 days [range, 0-84]). The median
of pro
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the surgical group (21 days [range, 0-365 days] in the
surgery group and 14 days [0-210 days] in the EVLA group
[P  .001]).
Minor, self-limiting complications were common in
both groups (Table V). In the surgery group, 1 patient
suffered from persistent saphenous nerve neuralgia, and
had remaining numbness of the skin after 1 year follow-up
after surgery. No deep venous thrombosis was reported.
Wound infection was reported in 10 surgically-treated pa-
tients (8%; P .03) and temporary parasthesia in 36 (27%;
P  .04) was also significantly more present in the surgery
group. A wound infection was defined as a swollen wound
with redness and/or heat, or when purulent was discharged
from the wound.
Tightness of the leg, defined as the experience of a
painful feeling of constriction, lasting longer than 7 days
postoperatively, was significantlymore present in the EVLA
group (n  19; P  .02). Hematomas, defined as a local-
ized collection of extravasated blood, were equally distrib-
uted between groups. All of the minor complications were
self-limiting within 3 months.
After a median follow-up period of 13.5 months
(range, 3-31) in the surgery group and 15.0 months
(range, 3-31) in the EVLA group (P  .06) clinical recur-
rences occurred in 25.8% of the surgically-treated limbs and
in 11.5% of limbs treated with EVLA (P  .024). This
observation did not remain significant after correction for
length of follow-up by Kaplan-Meier comparison (Fig).
The re-recurrence rates after 25 weeks of follow-up were
29% in the surgically-treated patients and 19% in the
EVLA-treated patients (P  .51).
Satisfaction. Patients in both groups gave similar
grades for their satisfaction with the treatment, 7.6  1.6
points and 7.5  2.0 points (P  .71) in the surgery- and
EVLA group, respectively. The preoperative grade given
for the subjective severity of symptoms was comparable:
7.0 1.5 points in the surgery group and 7.0 1.4 points
in the EVLA group. The experienced improvement of
Table V. Complications after treatment of recurrent varic
EVLA n  61, Surgery n  132 E
Minor complications
Ecchymosis n  51
Hematoma n  16
Induration n  20
Phlebitis n  4
Temporary parasthesia n  8
Tightness (7 days) n  19
Wound infection n  0
Major complications
Deep venous thrombosis n  0
Persistent saphenous neuralgia (1 year) n  1
GSV, Great saphenous vein; EVLA, endovenous laser ablation.
Data are presented as n and (%) unless otherwise specified. The number
undergone.symptoms, measured by deduction of the preoperativegrade of the current grade of symptoms, was also not
different between the groups (2.5  2.4 in the surgery
group, 2.7  2.6 in EVLA group).
DISCUSSION
In the present study, we have demonstrated that, if
anatomically suitable, EVLA is a good treatment alternative
for recurrent varicose veins of the GSV, also after previous
stripping. Socioeconomic outcomes are better and the
complication rate is lower after EVLA. Patient satisfaction
and clinical re-recurrences are equal in both groups. Surgically-
treated patients reported less postoperative pain but a
Fig. Kaplan-Meier survival curve showing re-recurrences after en-
dovenous laser ablation (EVLA) and surgical treatment of recur-
rent varicose veins of the great saphenous vein (GSV). P  .511
after log-rank (Mantell-Cox) comparison.
eins of the GSV with either surgery or EVLA (P  ns)
Surgery P value
84% n  114 86% .613
26% n  44 33% .322
33% n  48 36% .629
7% n  11 8% .668
13% n  36 27% .04
31% n  22 17% .02
0% n  10 8% .04
0% n  0 0% 0
1% n  0 0% .140
cedures indicates the amount of procedures that patients had previouslyose v
VLAhigher use of analgesic medication.
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could have been expected. It is more surprising that 36
previously stripped legs could also be treated. Anatomic
suitability on duplex scan is a prerequisite. In this series,
31% of patients with recurrences were treated with EVLA,
suggesting that tortuosity is a common contraindication for
endovenous treatment in these patients. Nevertheless, 10
patients having tortuous veins on preoperative duplex scan
were effectively treated with EVLA. Both the existence of
double system and neovascularization may partly explain
the feasibility of EVLA after previous stripping.
As in other series, minor self-limiting complications,
such as ecchymosis, hematoma, indurations, temporary
paresthesia, and delayed tightness were frequent. All of
these were more prevalent in the surgical group except for
the delayed tightness. A higher incidence of tightness in the
EVLA group could have been expected because the entire
length of the vein was ablated, in contrast to the surgical
group that underwent an SFD only. As could be expected,
wound infections only occurred in the surgical group. The
combination of temporary paresthesias and wound infec-
tion was 35% in the surgical group, which may be consid-
ered a significant price to pay when compared to the 13%
incidence after EVLA. Generally, treatment of recurrences
is considered to have higher complication rates than treat-
ment for primary varicosities.11 Our data do not confirm
this: only 1 surgically-treated patient had lasting saphenous
paralysis and there was no deep venous thrombosis in either
group. The occurrence of a temporary parasthesia was
significantly more frequent in the surgery group. The high
incidence after surgery is in accord with Morrison and
Dalsing,23 who have described that 40% of patients have
symptoms consistent with saphenous nerve injury at some
time after operation, but that these symptoms affected
quality of life in only 6.7%. The incidence of wound infec-
tions and hematomas may also be important because they
have been correlated with revascularization.24
In this study, patients treated with EVLA could return
to their working conditions in 2 days, which was signifi-
cantly shorter than surgically-treated patients, who needed
1 week. The minimally invasive character of EVLA, includ-
ing the absence of wounds, may have contributed to this
finding. This socioeconomic observation may have great
impact, considering the large number of patients treated
annually. Surprisingly, the increased postoperative pain in
EVLA-treated patients, did not refrain them from return-
ing to work. The lower use of analgesic medication in this
group might partly explain the increased experience of
postoperative pain. Higher pain scores after EVLA and a
longer duration of pain, however, have been reported in
previous studies.20,25 The amount of tumescent fluid used
during EVLA might have also contributed. Unfortunately,
these data were not recorded in the case files. The thermal
ablation of long segment of the saphenous vein may also
have contributed injury to the increased pain score and the
duration of postoperative pain in the EVLA group. Patients
who are treated conventionally usually are prescribed anal-
gesics for some days. After EVLA, in contrast, patients areadvised to use analgesics only when necessary. The obser-
vation of higher pain scores in EVLA-treated patients may
be used to better prepare patients preoperatively, informing
them on postoperative pain, and prescribing adequate pain
medication.
Clinical studies have suggested that the recurrence of
varicose veins after EVLA may be lower than after conven-
tional surgery.19,26 In our study, we found that the re-
recurrence rate was not different between groups, although
a tendency was observed towards a higher rate in the
surgery group. In the present study, we have measured
clinical recurrences only. Recurrences on duplex ultrasound
scans have been reported to be higher and might differ
between groups. Additional prospective trials are indicated
to illuminate this subject and the timing of re-recurrences.
In the present study, a remarkably high percentage of
the legs that had undergone previous GSV stripping were
found to have a GSV insufficiency on duplex scan. This
might be partly explained by the existence of a double
system, but may also indicate a role of neovascularization in
the pathophysiology of re-recurrences. The role of neovas-
cularization in the development of recurrences is still de-
bated. Some declare that it is the main cause for recurren-
ces,6,27 although others state that other causes, such as
persistent tributaries, are more important. Theivacumar
et al,28 however, found that the persistence of nonrefluxing
GSV tributaries at the SFJ did not have an adverse impact
on clinical outcome 1 year after EVLA. Additionally, Pitta-
luga et al29 described good results with regard to hemody-
namics and neovascularization on the SFJ, varicose vein
recurrence, improvement of symptoms, and aesthetic ap-
pearance after preservation of the SFJ during saphenous
stripping. The mechanisms of neovascularization are yet to
be discovered. In the event of neovascularization of the
ablated vein, Labropoulos et al30 proposed arteriovenous
fistulae as the responsible mechanism for recanalization.
With laser ablation the incompetent stump is not specifi-
cally treated, but the GSV stump shrinks and is reduced 3
months after EVLA.28,31 Recently, it was shown that al-
though duplex ultrasound scan is a reliable tool to diagnose
groin recurrences, its validity in classifying the different
types of recurrent groin vessels is limited.32 Histologic
examination should, therefore, be regarded as the gold
standard when trying to differentiate between different
types of groin recurrences. Further studies focusing on the
mechanisms of recurrences after both surgery and en-
dovenous techniques are indicated.
The retrospective design of this study may have in-
duced a selection bias. Patient selection on duplex ultra-
sound scan was mainly based on the anatomy. Severe
tortuosity, thrombus, and possible access difficulties were
considered to be exclusion criteria for EVLA. Patients with
cosmetic concerns were more abundant in the surgical
group. This might have been caused by a larger and more
complex vein pattern thus favoring results in the EVLA-
treated group. The preoperative clinical status as measured
with the CEAP classification, however, was worse in the
EVLA-treated group, which might have negatively affected
JOURNAL OF VASCULAR SURGERY
November 20091112 Groenendael et althe results in this group. Kambal et al33 have suggested that
EVLA may be more effective in the treatment of patients
with a severe clinical status. In our study, all patients were
included after introduction of EVLA in our institution.
Thus, these data also reflect the center’s initial experiences
in treating GSV varicosities with EVLA. A learning curve
may be expected that could have negatively affected the
results of the EVLA group. During the study period, con-
traindications for EVLA included severe tortuosity, throm-
bus, and a vein diameter of less than 4 mm. Currently, the
lower limit of diameter in our institution is 3 mm, indicat-
ing that some of the surgically-treated patients unrightfully
have been denied EVLA.
In conclusion, we have shown that EVLA is feasible in
patients with recurrent varicose veins of the GSV, even after
previous stripping. Complication rates are lower and socio-
economic outcome is better, compared to surgical reinter-
vention. Patient satisfaction is high for both treatment
modalities.
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